It is interesting to note that these active compounds act in a multi-targeted manner, such as regulating the levels of AMPK, PPAR, SREBP-1c, FAS, ACC, SIRT1, Nrf2, JNK and other proteins to improve NAFLD. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.